NCT03207152View on ClinicalTrials.gov

Biomarkers Predicting Infectivity in an Experimental Human Influenza Model

PHASE1UnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

May 8, 2018

Study Completion Date

February 28, 2019

Conditions

Influenza A

Interventions

BIOLOGICAL

Influenza A/California/04/09

Good Manufacturing Practices-certified Influenza A/California/04/09 3.5x10(4) TCID50 in 1 mL in DPBS delivered by intranasal drops

Trial Locations (1)

W12 0NN

Imperial College London, London

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

United States Department of Defense

FED

collaborator

Imperial College of London

UNKNOWN

lead

Duke University

OTHER